Aspen Aerogels, Inc. (NYSE:ASPN) Shares Bought by California State Teachers Retirement System

California State Teachers Retirement System lifted its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 8.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,039 shares of the construction company’s stock after buying an additional 4,734 shares during the period. California State Teachers Retirement System owned approximately 0.08% of Aspen Aerogels worth $1,057,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Banque Cantonale Vaudoise boosted its holdings in Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after acquiring an additional 1,252 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Aspen Aerogels by 15.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock valued at $257,000 after purchasing an additional 1,938 shares during the period. Thompson Davis & CO. Inc. grew its holdings in Aspen Aerogels by 14.7% during the 4th quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company’s stock valued at $381,000 after purchasing an additional 3,100 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after buying an additional 3,607 shares during the period. Finally, Zevenbergen Capital Investments LLC lifted its holdings in Aspen Aerogels by 2.4% in the 4th quarter. Zevenbergen Capital Investments LLC now owns 280,802 shares of the construction company’s stock worth $4,431,000 after buying an additional 6,575 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling

In other Aspen Aerogels news, CEO Donald R. Young sold 256,944 shares of the company’s stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $29.24, for a total value of $7,513,042.56. Following the transaction, the chief executive officer now owns 502,855 shares of the company’s stock, valued at $14,703,480.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 4.30% of the stock is currently owned by insiders.

Aspen Aerogels Trading Up 1.8 %

Shares of Aspen Aerogels stock opened at $23.47 on Wednesday. The business has a fifty day simple moving average of $24.83 and a 200-day simple moving average of $20.89. The firm has a market cap of $1.79 billion, a price-to-earnings ratio of -53.33 and a beta of 2.15. Aspen Aerogels, Inc. has a fifty-two week low of $5.32 and a fifty-two week high of $31.74. The company has a quick ratio of 3.29, a current ratio of 4.01 and a debt-to-equity ratio of 0.24.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The company had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. Aspen Aerogels’s revenue was up 144.4% on a year-over-year basis. During the same period in the prior year, the company earned ($0.22) EPS. On average, equities analysts forecast that Aspen Aerogels, Inc. will post 0.12 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on ASPN shares. Craig Hallum lifted their target price on Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research report on Friday, June 14th. Barclays started coverage on Aspen Aerogels in a report on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price objective on the stock. B. Riley raised shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, June 25th. Piper Sandler upped their price target on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a report on Wednesday, May 29th. Finally, Benchmark reissued a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and an average target price of $29.20.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.